| 000 | 01654 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515042717.0 | ||
| 264 | 0 | _c20070212 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 024 | 7 |
_a10.1124/jpet.106.108159 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVernon, Anthony C | |
| 245 | 0 | 0 |
_aSelective activation of group III metabotropic glutamate receptors by L-(+)-2-amino-4-phosphonobutryic acid protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cJan 2007 |
||
| 300 |
_a397-409 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a3,4-Dihydroxyphenylacetic Acid _xanalysis |
| 650 | 0 | 4 |
_aAminobutyrates _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aHomovanillic Acid _xanalysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 |
_aPhosphoserine _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Metabotropic Glutamate _xdrug effects |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
| 700 | 1 | _aZbarsky, Virginia | |
| 700 | 1 | _aDatla, Krishna P | |
| 700 | 1 | _aDexter, David T | |
| 700 | 1 | _aCroucher, Martin J | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 320 _gno. 1 _gp. 397-409 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.106.108159 _zAvailable from publisher's website |
| 999 |
_c16590171 _d16590171 |
||